Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
Zain
Saami
S
Antitrust Bureau, New York State Office of the Attorney General, USA.
D016363:Antitrust Laws; D016527:Drug Costs; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004348:Drug Labeling; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution*; D004465:Economic Competition / Q000331:legislation & jurisprudence; D006801:Humans; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence* / Q000379:methods; D008484:Medicaid; D006278:Medicare; D014481:United States; D014485:United States Federal Trade Commission; D014486:United States Food and Drug Administration
D016568:Drugs, Generic